EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Platelet membrane-modified exosomes targeting plaques to activate autophagy in vascular smooth muscle cells for atherosclerotic therapy

Yu Jiang, Zhi-Yao Wei, Zhi-Feng Song, Miao Yu, Ji Huang, Hai-Yan Qian iD

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-025-01792-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Yu Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Coronary Heart Disease, Department of Cardiology, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovasc…. Hauptthemen laut MEDLINE: Exosomes, Muscle, Smooth, Vascular, Atherosclerosis, Blood Platelets. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is one of the leading causes of ischemic cardiovascular disease worldwide. Recent studies indicated that vascular smooth muscle cells (VSMCs) play an indispensable role in the progression of atherosclerosis. Exosomes derived from mesenchymal stem cells (MSCs) have demonstrated promising clinical applications in the treatment of atherosclerosis. However, there are still challenges and limitations persist in targeted therapy. This study aims to develop a bionic nano-delivery system by fusing platelet membranes with exosomes (MSC-Exo P ) and explore the anti-atherosclerosis effect of MSC-Exo P by improving the targeting efficiency and participating in regulating the pathophysiological processes associated with VSMCs. The morphology, particle size, stability, and fusion efficiency of MSC-Exo P were assessed using transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), immunofluorescence staining, and Western blotting, respectively. MSC-Exo P was administered intravenously into ApoE −/− mice via the tail vein. In vivo, immunofluorescence staining was used to assess the targeting efficacy of MSC-Exo P . The ORO staining, H&E staining, Masson staining, aortic root immunofluorescence staining, and Western blot were utilized to evaluate the VSMC autophagy and anti-atherosclerosis effects of MSC-Exo P . In vitro, the autophagy activation of MSC-Exo P on VSMCs was further assessed by immunofluorescence staining and Western blotting. The effects of MSC-Exo P on VSMCs proliferation, migration, and foam cell formation were detected by EdU experiment, Transwell experiment, wound healing experiment, ORO staining, and BODIPY staining. The TEM revealed that MSC-Exo P retained a ring nanostructure, which was similar to MSC-Exo in morphology. NTA analysis indicated the MSC-Exo P exhibited a slight increase after cell membrane fusion. Besides, the stability analysis of exosomes and MSC-Exo P resulted in no significant changes in particle size. Western blot analysis confirmed that MSC-Exo P simultaneously expressed platelet-specific markers (GPVI, GPIbα, CD62P) and exosome-specific markers (CD81, TSG101, and Alix). In ApoE −/− mice, the immunofluorescence of aorta and its roots was significantly enhanced after injection of DiI-labeled MSC-Exo P , indicating enhanced targeting of MSC-Exo to atherosclerotic plaques by platelets. In vivo experiments demonstrated that MSC-Exo P could significantly suppress the progression of atherosclerosis and reduce the area of atherosclerotic plaques by reducing lipid deposition and necrotic nucleus area and increasing collagen content. In vitro experiments further revealed that the uptake of MSC-Exo P by foam cells significantly increased, and their proliferation, migration, and foam formation were inhibited by autophagy activation. This study demonstrated successful fusion of platelet membranes with exosomes derived from MSCs. MSC-Exo P could significantly improve the targeting efficiency of atherosclerosis and play an anti-atherosclerosis effect by activating VSMC autophagy. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMuscle, Smooth, VascularAtherosclerosisBlood PlateletsPlaque, AtheroscleroticAnimalsAutophagyMiceMaleMyocytes, Smooth MuscleMesenchymal Stem CellsMice, Inbred C57BLCells, Cultured

Stichwörter der Autor:innen

AtherosclerosisAutophagyExosomeTargeting deliveryVascular smooth muscle cells

Autor:innen und Institutionen

  • Center for Coronary Heart Disease, Department of Cardiology, National Center for Cardiovascular Diseases of China, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, Chinese Academy of Medical Sciences and…
  • Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung, and Blood Vessel Diseases, Capital Medical University, National Clinical Research Center for Cardiov…

ORCID-Profile: Hai-Yan Qian

Zitieren

APA

Jiang, Y., Wei, Z. Y., Song, Z. F., Yu, M., Huang, J., & Qian, H. Y. (2025). Platelet membrane-modified exosomes targeting plaques to activate autophagy in vascular smooth muscle cells for atherosclerotic therapy. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-025-01792-1

Vancouver

Jiang Y, Wei ZY, Song ZF, Yu M, Huang J, Qian HY. Platelet membrane-modified exosomes targeting plaques to activate autophagy in vascular smooth muscle cells for atherosclerotic therapy. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-025-01792-1

BibTeX
@article{Jiang2025,
  author = {Jiang, Yu and Wei, Zhi-Yao and Song, Zhi-Feng and Yu, Miao and Huang, Ji and Qian, Hai-Yan},
  title = {Platelet membrane-modified exosomes targeting plaques to activate autophagy in vascular smooth muscle cells for atherosclerotic therapy},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-025-01792-1}
}
Kostenlos starten →